PMID- 26802140
OWN - NLM
STAT- MEDLINE
DCOM- 20180521
LR  - 20181202
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 214
IP  - 1
DP  - 2016 Jul 1
TI  - Long-term Protection After Hepatitis B Vaccine.
PG  - 1-3
LID - 10.1093/infdis/jiv750 [doi]
FAU - Van Damme, Pierre
AU  - Van Damme P
AD  - Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute,
      Antwerp University, Belgium.
LA  - eng
PT  - Editorial
PT  - Research Support, Non-U.S. Gov't
PT  - Comment
DEP - 20160121
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
RN  - 0 (Hepatitis B Antibodies)
RN  - 0 (Hepatitis B Surface Antigens)
RN  - 0 (Hepatitis B Vaccines)
SB  - AIM
SB  - IM
CON - J Infect Dis. 2016 Jul 1;214(1):16-22. PMID: 26802139
MH  - Hepatitis B
MH  - *Hepatitis B Antibodies
MH  - Hepatitis B Surface Antigens
MH  - *Hepatitis B Vaccines
MH  - Humans
MH  - Immunization, Secondary
OTO - NOTNLM
OT  - *duration
OT  - *hepatitis B
OT  - *protection
OT  - *vaccine
EDAT- 2016/01/24 06:00
MHDA- 2018/05/22 06:00
CRDT- 2016/01/24 06:00
PHST- 2015/12/10 00:00 [received]
PHST- 2015/12/10 00:00 [accepted]
PHST- 2016/01/24 06:00 [entrez]
PHST- 2016/01/24 06:00 [pubmed]
PHST- 2018/05/22 06:00 [medline]
AID - jiv750 [pii]
AID - 10.1093/infdis/jiv750 [doi]
PST - ppublish
SO  - J Infect Dis. 2016 Jul 1;214(1):1-3. doi: 10.1093/infdis/jiv750. Epub 2016 Jan
      21.